A Phase II study of a histamine H3 receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy - Concepedia

Concepedia

Publication | Closed Access

A Phase II study of a histamine H3 receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy

66

Citations

16

References

2015

Year

L. Fredrik Jarskog, Martin T. Lowy, Richard Grove, Richard S.E. Keefe, Joseph P. Horrigan, M. Patricia Ball, Alan Breier, Robert W. Buchanan, Cameron S. Carter, John G. Csernansky,

Schizophrenia Research

PsychiatryPsychotic DisorderAntipsychotic TherapyCognitive DysfunctionStable Schizophrenia SubjectsPsychopharmacologySchizophreniaPhase Ii StudySocial SciencesNeuroscienceMedicinePsychopathology

References

	Year	Citations

Page 1

Page 1